Latest Breaking News On - Dr reddys research and developmentb v - Page 1 : comparemela.com

"The agreed consideration for the assets and liabilities of the said site is EUR 1. Further DRRDBV has agreed to pay to the purchaser a compensation of EUR 11.35 million for certain operating expenses.

United statesAndhra pradeshNew delhiAurigene pharmaceutical servicesDndi india foundationDr reddy researchDelpharm development leidenDr reddy labsDelpharm groupReddy laboratories ltdFrance based delpharm groupAurigene pharmaceutical services limitedNeglected diseasesDr reddys labsDr reddys labs newsDr reddys research and developmentb v